1
Center of Pharmacoeconomics, Milan, Italy; 2 Haemophilia and Thrombosis Centre, Milan, Italy OBJECTIVES: Regular prophylactic replacement therapy has been proved to provide a better quality of life in children with haemophilia compared to those treated when bleeding occurs (on-demand treatment). No data is available in adults. The aim of this study is the evaluation and comparison of health-related quality of life (HRQoL) in patients who switched from ondemand therapy to prophylaxis. METHODS: A prospective, open study design was chosen. Patients receiving on demand treatment aged 18 years or more and affected by severe haemophilia A were enrolled at two Italian haemophilia care centres at the moment of their switching to prophylaxis therapy.
Information related to the on-demand treatment time period (ODT), six months before enrolment, and to the prophylaxis time period (PT), six months after enrolment, has been obtained at baseline and at the end of the follow-up period. Two generic HRQoL questionnaires, EuroQol (EQ-5D) and Short Form 36 (SF-36) have been used, higher score corresponding to better quality of life. RESULTS: Ten patients returned HRQoL questionnaire: the median age was 31.9 years (ranging from 23 to 58 years). At the end of the follow-up period, SF-36 showed a statistically significant improvement in patients quality of life in some domains ("Physical Functioning" and "Bodily Pain", p < 0.05) and in the Physical Component Summary (mean score after ODT 43.9 vs. 48.3 after PT, p < 0.05). Results obtained with EuroQol-5D were comparable to those showed by SF-36, with significantly different Visual Analogue Scale scores after ODT vs. after PT (67.9 and 72.9 respectively, p < 0.05). CONCLUSIONS: Prophylaxis therapy in adult patients with severe haemophilia showed to provide a significant improvement in HRQoL and it should therefore be considered in a cost utility evaluation.
PHM7 DISEASE STATE AND QUALITY OF LIFE IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES: A REVIEW OF INSTRUMENTS, DISEASE BURDEN, AND PREDICTIVE FACTORS FOR OUTCOMES
Szende A 1 , Wang M 2 , Husbands C 3 , Schaefer C 3 , Goss TF 3 1 Covance Health Economics and Outcomes Services, Leeds, West Yorkshire, UK; 2 Celgene Corporation, Sumit, NJ, USA; 3 Covance Health Economics and Outcomes Services, Gaithersburg, MD, USA OBJECTIVES: To review and evaluate available QOL instruments in MDS, the QOL burden of MDS, disease characteristics that influence QOL outcomes, and to provide recommendations for future research. METHODS: A systematic literature review was performed to identify QOL studies performed in MDS patients and published in English from 1995 to 2005. RESULTS: A total of 53 abstracts were located; 13 studies were selected for review. The FACT-An, EORTC QLQ-C30, Quality of Life-E (QOL-E), and SF-36 all demonstrated acceptable validity in MDS patients. The FACT-An, QOL-E, and SF-36 had good internal consistency with Cronbach's alpha coefficients for subscales ranging from 0.92 to 0.94, 0.72 to 0.88, and 0.75 to 0.94, respectively. The FACT-An and EORTC QLQ-C30 showed appropriate responsiveness to change in prospective randomized trials. Two studies compared QOL among MDS patients with the general population. Statistically significantly (p < 0.05) worse QOL was observed in the following domains: fatigue, physical functioning, role physical, vitality, social functioning, emotional functioning, and global health. Cognitive functioning was least affected. No study stratified QOL differences by MDS disease sub-group categories or International Prognostic Scoring System (IPSS) risk scores. However, four studies established a link between transfusion independence and better QOL. All studies found QOL to be significantly (p < 0.05) better in transfusionindependent patients, even after controlling for haemoglobin level. Six studies found improvements in clinical status were associated with improved QOL. Changes in overall QOL were mostly linked to improvements in the fatigue, dyspnea, physical, and social functioning QOL sub-scales. CONCLUSIONS: MDS leads to significant QOL burden compared to similarly aged adults in the general population. QOL is an important endpoint in MDS research. Several validated instruments are available. Evidence on the clear link between transfusion dependency and impaired QOL suggests a potentially important role for new treatments that achieve higher transfusion independence among MDS patients.
